Trust Size
$53M
Peak Price
$105.40
Current Price
$0.90
Return
-91.0%
What Happened
Senti Biosciences, Inc. (SNTI) filed its S-1 registration in 2021 and completed its business combination in 2022. The company remains actively traded with 309 SEC filings on record.
Senti Biosciences, Inc. entered the SPAC market in 2021 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2022.
SEC records show 309 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2021-05-21
S-1 Registration Filed
2022-05-13
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1854270
Total SEC Filings
309
State of Incorporation
DE
Last Filing Date
2026-03-19
Business Location
Redwood City, CA
Trust/Asset Size
$53M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Senti Biosciences